Anixa Biosciences Common Stock

The latest common stock for ANIX is $340K as of April 2026. That compares with $320K in the prior-year period — up 5.3% year over year. Investors often review this figure alongside Anixa Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, ANIX's common stock moved from $320K to $340K — a 5.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Anixa Biosciences's operating scale or balance-sheet position.

A common stock figure of $340K for ANIX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ANIX's common stock ($340K), review year-over-year change from $320K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Anixa Biosciences's common stock against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.